CAMPBELL MURRAY

Profile

First Name

: CAMPBELL

Middle Name

:

Last Name

: MURRAY

Related Companies
Titles
Company Name
Related People
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2026-04-22 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-06-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-11 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-07 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-30 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Debt 
2017-05-23 
D/A
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-17 
D
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-17 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2016-12-23 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2016-02-24 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-10-31 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2016-02-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-03-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-31 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2016-02-24 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-01 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2012-10-11 
D/A
OTHER TECHNOLOGY 
 
NO REVENUES 
Equity 
2012-10-11 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-09 
D/A
OTHER TECHNOLOGY 
 
NO REVENUES 
Equity 
2012-10-11 
D/A
OTHER TECHNOLOGY 
 
NO REVENUES 
Equity 
2012-10-11 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-07-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-07 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-22 
D/A
OTHER TECHNOLOGY 
 
NO REVENUES 
Equity 
2012-10-11 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-28 
D/A
OTHER TECHNOLOGY 
 
NO REVENUES 
Equity 
2012-10-11 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-13 
D/A
OTHER TECHNOLOGY 
 
NO REVENUES 
Equity 
2012-10-11 
D
OTHER TECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2012-11-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-08-28 
D
OTHER TECHNOLOGY 
 
NO REVENUES 
Equity 
2012-10-11 
D/A
OTHER TECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2010-07-20 
D/A
OTHER TECHNOLOGY 
 
NO REVENUES 
Equity 
2012-03-02 
D/A
OTHER TECHNOLOGY 
 
NO REVENUES 
Equity 
2012-03-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-23 
D/A
OTHER TECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2010-07-20 
D
OTHER TECHNOLOGY 
 
NO REVENUES 
Equity 
2012-03-02 
D
OTHER TECHNOLOGY 
 
NO REVENUES 
Equity 
2012-03-02 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2012-03-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-12-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-09-09 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-24 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-06 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-04-06 
D/A
OTHER TECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2010-07-20 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-12-14 
D
OTHER TECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2010-07-20 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2008-12-23 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-09 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-09 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2008-12-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-05-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-05-06